Resistance to Antibiotics is Ancient

Article

Scientists were surprised at how fast bacteria developed resistance to the miracle antibiotic drugs when they were developed less than a century ago. Now scientists at McMaster University have found that resistance has been around for at least 30,000 years.

McMaster evolutionary geneticist Hendrik Poinar, left, and Gerry Wright, scientific director of the Institute for Infectious Disease Research, are pictured in Wright's lab.

Scientists were surprised at how fast bacteria developed resistance to the miracle antibiotic drugs when they were developed less than a century ago. Now scientists at McMaster University have found that resistance has been around for at least 30,000 years.

Research findings published today in the science journal Nature show antibiotic resistance is a natural phenomenon that predates the modern clinical antibiotic use. Principal investigators for the study are Gerry Wright, scientific director of the Michael G. DeGroote Institute for Infectious Disease Research and Hendrik Poinar, McMaster evolutionary geneticist.

"Antibiotic resistance is seen as a current problem and the fact that antibiotics are becoming less effective because of resistance spreading in hospitals is a known fact," says Wright. "The big question is where does all of this resistance come from?"

After years of studying bacterial DNA extracted from soil frozen in 30,000-year-old permafrost from the Yukon Territories, the researchers were able to develop methods to isolate DNA within McMasters Ancient DNA Centre. Using state-of-the-art molecular biological techniques, methods were developed to tease out small stretches of ancient DNA.

Researchers discovered antibiotic resistant genes existed beside genes that encoded DNA for ancient life, such as mammoths, horse and bison as well as plants only found in that locality during the last interglacial period in the Pleistocene era, at least 30,000 years ago. They focused on a specific area of antibiotic resistance to the drug vancomycin, a significant clinical problem that emerged in 1980s and continues to be associated with outbreaks of hospital-acquired infections worldwide.

This is only the second time an ancient protein has been revived in a laboratory setting.

Wright said the breakthrough will have important impact on the understanding of antibiotic resistance: "Antibiotics are part of the natural ecology of the planet so when we think that we have developed some drug that wont be susceptible to resistance or some new thing to use in medicine, we are completely kidding ourselves. These things are part of our natural world and therefore we need to be incredibly careful in how we use them. Microorganisms have figured out a way of how to get around them well before we even figured out how to use them."

Poinar says this discovery has opened doors for ancient antibiotic resistance research. "We can go back a million years in the permafrost, which is our next goal."

Funding for this project came from the Canada Research Chairs program, the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council.

Recent Videos
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Related Content